News #ECTRIMS2018 – Shifting from Gilenya to Lemtrada Doesn’t Increase Risk of MS Reactivation, Study Says

News #ECTRIMS2018 – Evobrutinib and Other Reasons for Hope in Pursuit of MS Treatments, Jerry Wolinsky Says in Interview

News #ECTRIMS2018 – MS PATHS Just Starting to See Potential, Aims for Remission as Treatment Goal, Biogen Exec Says

News #ECTRIMS2018 – Two European Studies Compare Tecfidera, Aubagio Effectiveness

Alexa, News #ECTRIMS2018 – Study Examines Relapses When Stopping Gilenya During, After Pregnancy

Columns, Faith of the Mustard Seed - a Column by Debi Wilson PPMS Suddenly and Spontaneously Surges My Symptoms

News #ECTRIMS2018 – Additional Analysis on Ozanimod Demonstrate Its Potential to Treat Relapsing MS

News #ECTRIMS2018 – Post-hoc Analyses Support Safety and Efficacy of Mavenclad, Merck Says

News #ECTRIMS2018 — As Siponimod Awaits FDA Decision, Mouse Work Helps in Understanding Benefits Seen in SPMS

News #ECTRIMS2018 – Plasma Neurofilament Light Levels Linked to Treatment Effects in RRMS, Study Finds

News #ECTRIMS2018 – Smoking and Vitamin D Deficiency Likely to Worsen CIS Prognosis, Model Suggests

News #ECTRIMS2018 – Excessive Weight, But Not Vitamin D, Linked with Faster Grey Matter Loss in MS, Study Finds

Columns, Fall Down, Get Up Again- a Column by John Connor A Black Mark for the Black Cab

Columns, The MS Wire - A Column by Ed Tobias MS Patients Capture the Ear of a Pharma Company

News #ECTRIMS2018: Study Proposes Serum Neurofilament Light Threshold to Identify RRMS Patients at Risk of Worsening

News #ECTRIMS2018 — In CIS Patients, Early Lesions in Specific Brain Area Linked to Worse Disability 30 Years Later, Study Shows

News #ECTRIMS2018 – From Sun to Salt: Growing Role of Environment in MS

News #ECTRIMS2018 — Early Relapses and Larger Lesions Increase Risk of Developing SPMS, Study Reports

News #ECTRIMS2018 – MS Patients More Prone to Health Problems Before, After Diagnosis, Study Suggests

Columns, Engaging Thoughts Circumvention Tourism, Revisited

News #ECTRIMS2018 — Infections, Severe Disability Complications More Likely Causes of Death in MS Patients, Study Shows

News #ECTRIMS2018 — MS Patients with Depression or Bipolar Disorder at Higher Risk of Disability Worsening, Study Finds

News #ECTRIMS2018 – Brain, Spinal Cord Injuries Affect Processing Speed in MS Patients, Study Reveals

News #ECTRIMS2018 — Data from 2 EU Trials Shows Effectiveness of Cannabidiol Spray in Treating Spasticity

News #ECTRIMS2018 – Rituximab for MS Does Not Increase Cancer Risk Compared to Gilenya and Tysabri, Swedish Study Finds

News #ECTRIMS2018 – Lower Mortality Rate in US, Sweden for MS Patients Treated With Rituximab, Study Reports

Columns, MS in Motion - A Column by Mike Knight Pill Stopper: Why I’m Off My Meds

News #ECTRIMS2018 — Vitamin D May Boost Glucocorticosteroid Effectiveness in MS Relapses, Study Suggests

News #ECTRIMS2018 – Switching to Tysabri Leads to Fewer Relapses and Disability than Gilenya, Study in RRMS Patients Finds

News #ECTRIMS2018 – DMTs Slow Down Disability Progression in SPMS Patients with Ongoing Relapses, Analysis Shows

News #ECTRIMS2018 — Merck KGaA to Present Latest Data on MS Portfolio

News #ECTRIMS2018 – Researcher Presents Data About Myelocortical MS, a New Disease Subtype

News FDA, EMA Agree to Review Novartis Therapy Siponimod to Treat SPMS

Columns, The MS Wire - A Column by Ed Tobias Buddy, Can You Give Me a Lift to the Doctor?

News Pregnancy Rates Rise Among Women with MS Over Past Decade in US, Study Shows

News EMD Serono, ACP Work Jointly to Make MS Clinical Trials More Patient-focused

Columns, Faith of the Mustard Seed - a Column by Debi Wilson October Is National Disability Employment Awareness Month

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: aHSCT and Fatigue, What’s Hot at ECTRIMS?, Genes that May Impact MS

News National MS Society Awards $12M to 40 Research Projects in US and Elsewhere

News UVA Scientist Awarded $5.6M by NIH to Further Study Lymph System and Brain Connection

A Life in Letters -- A Column By Jamie Hughes, Columns What the World Needs Now is Books

Columns, Fall Down, Get Up Again- a Column by John Connor Don’t Turn Anything Down!

Columns, The MS Wire - A Column by Ed Tobias Could Government Probe Threaten Pharma Patient Assistance Programs?

News #ECTRIMS2018 — Biogen’s MS Treatments Found Safe, Effective in Clinical and Real-world Data

Columns, Silver Linings - a Column by Jennifer Powell MS-related Insomnia is Exhausting

News #ECTRIMS2018 – Genentech to Present Ocrevus-related MS Studies at Conference

News #ECTRIMS2018 – Emerging MS Treatments, from Cannabinoids to Diet, Among Highlights at Conference

News Risk of Kidney Deterioration Low in MS Patients, Study Suggests

News NMSS Praises Federal Funding of Data Collection for MS, Other Diseases

Columns, The MS Wire - A Column by Ed Tobias MS Patient Argues Over Where She Had Parked — And Won!

News New Genetic Variants Linked to Aggressive or Benign MS Disease Course, Study Shows

News Lower Fatigue Reported by MS Patients after aHSCT in Canadian Study

Columns, Faith of the Mustard Seed - a Column by Debi Wilson Neglecting Your Dental Hygiene Can Hurt Your MS

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: MRI Signal, Cost-effective DMTs, Age Benefits, Generic Ampyra

News Cannabidiol-derived Treatment for MS, EHP-101, Enters Phase 1 Safety Study, Emerald Health Says

News MS Patients Using Rebif Not at Higher Stroke Risk, Even Over Long-term, Study Reports

Columns, Fall Down, Get Up Again- a Column by John Connor The Morning After the Night Before

Columns, The MS Wire - A Column by Ed Tobias Serious DMTs Need Serious Care Coordination

News New Assessment Tool Shows Effect of Social Networks on MS Patient Outcomes

News #ECTRIMS2018 – Ublituximab Markedly Reduces Lesions, Promotes B-cell Depletion, Halts Disability Progression in Phase 2 Trial

Columns, Silver Linings - a Column by Jennifer Powell Navigating Roadblocks with SPMS

News Smoking May Speed Up MS Progression, Lower Treatment Effectiveness, Study Reports

News Often-overlooked MRI Signal May Aid in Early Diagnosis of MS, Other Brain Conditions, Study Suggests

News Nyrada Identifies Novel IRAK4 Inhibitors that May Prevent Neuroinflammation

News DMTs Are Cost-Effective and Help to Slow MS Progression, 10-Year Study from UK Reports

Columns, Patiently Awakened - A Column by Teresa Wright-Johnson The Power of the Patient Advocate

Columns, The MS Wire - A Column by Ed Tobias Wearables Focus on Tracking Your Health

News With Age, Depression Lessens and Quality of Life Improves in MS Patients, Researchers Report

News Dalfampridine ER Tablets, Generic Version of Ampyra, Now Available in US, Mylan Announces

News CHMP Favors Approving Gilenya to Treat Children and Teenagers with RRMS in Europe

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: Treating MS with a Statin, Ocrevus, Remyelination

News Oligodendrocytes, Cells That Produce Myelin, Can Be Generated from Astrocytes, Study Reports

A Life in Letters -- A Column By Jamie Hughes, Columns What the Scan Said (and What It Didn’t)

Columns, Fall Down, Get Up Again- a Column by John Connor A Pain in the Back, Part 2

Columns, The MS Wire - A Column by Ed Tobias Pharma Exec Calls a 400 Percent Price Hike ‘Moral.’ Is it?

News Processing Speed Training May Help Improve Cognitive Function in MS Patients, Pilot Study Suggests

News Ocrevus Climbing as First-line DMT for RRMS Among Neurologists Surveyed in Spherix Report

Columns, Silver Linings - a Column by Jennifer Powell I Have MS and I Am Beautiful

News Rapamycin, Approved for Other Indications, Potentially Effective for MS, Study Suggests

News Lymphatic Vessels of Brain Carry Messages That Appear to Promote MS, Study Reports

News GeNeuro to Develop the MS Clinical Program of GNbAC1 Without Servier

News Ceramides Play Role in White Blood Cell Infiltration of Central Nervous System in MS

Columns, The MS Wire - A Column by Ed Tobias A Generic for Ampyra Could Be Released Soon

News Ibudilast Slows Brain Shrinkage 48% in Progressive MS Patients in Phase 2 Trial; Lead Researcher Says Finding is ‘Remarkable’

News Grant Awarded to Research New Method to Treat Cognitive Dysfunction in Progressive MS

Columns, Faith of the Mustard Seed - a Column by Debi Wilson This Is What Excites Me About Remyelination Therapy Research

News Gilenya More Effective Than Avonex in Lowering Relapse Rates, New Lesions in Children with Relapsing MS, Phase 3 Trial Shows

News MS Society of Canada Backs Study of Exercise and Rehabilitation in Aiding Cognition in Progressive Patients

Lemtrada Sponsored Content Staying Positive While Living with a Chronic Illness [Sponsored Post]

Columns, Fall Down, Get Up Again- a Column by John Connor A Pain in the Back, Part 1

News Phase 3 Trial in UK Soon to Test Statin, Simvastatin, in Slowing SPMS Progression

News Phagocytes, Key Immune Cells, Seen to Switch from Promoting to Repairing MS Lesions in Study

Columns, Silver Linings - a Column by Jennifer Powell Relationships Can Thrive with MS

News Video Testimonials Extol Benefits of PACE to Patients, Caregivers and Elderly

News, Ocrevus Ocrevus Increases Proportion of PPMS Patients with No Disease Progression or Activity, Phase 3 Trial Shows

Columns, MS in Motion - A Column by Mike Knight Out on a Stim: My FES Journey Comes to an End (Part 3)

News Fat Carrier Protein May Protect Nerve Cells, Help Myelin Regrow During MS, Research Suggests

News NICE Rules Against Bringing Ocrevus into NHS for Primary Progressive Patients in UK

Columns, Patiently Awakened - A Column by Teresa Wright-Johnson The Legacy I Hope to Leave Behind

Columns, The MS Wire - A Column by Ed Tobias Things to Know About Flu Shots if You Have MS